on-pharmacological therapy of delirium in intensive care units involving family members
- Conditions
- F05.0Delirium not superimposed on dementia, so described
- Registration Number
- DRKS00029085
- Lead Sponsor
- niversitätsklinikum Augsburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Patient = 18 years
- Presence of postoperative delirium
- ICDSC >3
- Presence of legal guardianship or information according to the presumed will expressed by the relatives with subsequent establishment of guardianship
- Relatives are personally and temporally able to participate in the study.
- Patient is expected to remain in the intensive care unit or IMC for more than 2 days.
- Informed consent is available
- Acute neurological or neurosurgical cerebral disease with cognitive impairment (ischemia, hemorrhage, brain tumor).
- Chronic neurologic or neurosurgical cerebral disease with cognitive impairment is present (ischemia, hemorrhage, brain tumor, dementia)
- patient expected to die within the next 72 h
- Delirium cannot be recorded (language barrier, aphasia)
- Patient who has a personal relationship to the person conducting the study
- Patient who is institutionalized by court or official order
- Patient who is pregnant or breastfeeding
- Alcohol and/or substance intoxication/overdose or withdrawal is present
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of delirium during intensive or intermediate care stay.
- Secondary Outcome Measures
Name Time Method Duration and dose of pharmacological measures for delirium therapy as well as duration of fixation measures, length of stay in intensive care and hospital, mortality after 28 days. In addition, it will be assessed how the relatives perceived the stay.